期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

甲状旁腺激素促进骨形成的研究进展 被引量：4

下载PDF
导出
作者 朱亚兰 姚伟 乐超银 何正权 梁宏伟 梁薇
机构地区 三峡大学生物技术研究中心
出处 《山东医药》 CAS 北大核心 2006年第7期79-80,共2页 Shandong Medical Journal
基金 湖北省教育厅青年基金项目(Q2005B002)
关键词 甲状旁腺激素 骨质疏松症 药物治疗 激素调节
分类号 R681 [医药卫生—骨科学]
  • 相关文献

参考文献9

  • 1Kneissel M,Boyed A,et al.Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone analog SDZPTS893or human PTH(1-34)[J].Bone,2001,28:237-250.
  • 2Seebach C,Skripitz P,Andreassen TT,et al.Imtemittent parathyroid hormone(1-34)enhance mechanical strength and density of new bone after distraction osteogenesis in rats[J].Orthop Res,2004,22(3):472-478.
  • 3王洪复,金慰芳,高建军,顾淑珠,周轶,孙爱龙,胡菲,沈洁,张顺昌.重组人甲状旁腺激素_(1-34)对去卵巢大鼠骨质疏松的治疗作用[J].中国医学科学院学报,2003,25(3):275-279. 被引量：25
  • 4金慰芳,王洪复,顾淑珠,周轶,高建军,徐培康,徐爱红,王漪,周永春.rhPTH_(1-34)治疗糖皮质激素诱发大鼠骨质疏松症的实验研究[J].中国骨质疏松杂志,2004,10(4):461-465. 被引量：6
  • 5Nakazawa T,Nakajima A,Shiomi K,et al.Effects of low-dose,intermittent treatment with recombinant human parathyroid hormone(1-34) on chondrdgenesis in a model of experimental fracture healing[J].Bone,2005,37(5):711-719.
  • 6Neer RM,Arnaud CD,Zanchetta JR,et al.Effect of parathyroid hormone(1-34) on fractures and bone mineral densith in postmenopausal women with osteoporosis[J].N Engl J Med,2001,344(19):1434-1441.
  • 7Orwoll ES,Scheele WH,Paul S,et al.The effect of teripratide[human parathyroid hormone(1-34)]therapy on bone density in men with osteoporosis[J].J Bone Mineral Research,2003,18(1):9-17.
  • 8Cosmen F,Nieves J,Zion M,et al.Parathyroid hormone in women receiving alendronate[J].N Engl J Med,2005,353(6):566-75.
  • 9Miao D,He B,Andrew CK,et al.Parathyroid hormone is essential for normal fetal bone formation[J].Clin Imvest,2002,109(9):1173.

二级参考文献22

  • 1[1]Shen V, Dempster DW, Mellish RW, et al. Effects of combined and separate intermitten administration of low-dose human parathyroid hormone fragment(1-34) and 17 β-estradiol on bone histomrphometry inovari-ectomied rats with established osteopenia. Calcif Tissue Int, 1992, 50:214-220.
  • 2[2]Baumann BD, Wronski TJ. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone, 1995,16: 247-253.
  • 3[3]Ejersted C, Andreassen TT, hauge EM. Parathyoid hormone(1-34) increasesvertebral bone mass, compressive strength, and quality in old rats.Bone, 1995, 17:507-551.
  • 4[4]Dempaser DW, Cosman F, Parisien M, et al. Anabolic actins of parathyroid hormone on bone. Endocrine Rev, 1993,14:690-709.
  • 5[5]Miller SC, Hunziker J, Mecham M, et al. Intermittent parathyroid hormone administration stimulates bone formation in the mandibles of aged overiectomiged rats. J Dent Res, 1997,76:1471-1476.
  • 6[6]Ejersted C, Andeassen TT, Hauge EM, et al. Parathyroid hormone(1-34) in creases vertebral bone mass, compressive strength, and quality in old rats. Bone, 1995,17:507-511.
  • 7[7]Hunziker J, Wronski TJ, Miller SC. Mandibular bone formation rates in aged ovariectomized rats treated with anfi-resorptive agents alone and in combination with intermittent parathyriod hormone. J Dent Res, 2000,79:1431-1438.
  • 8[8]Brommage R, Hotchkiss CE, Less C J, et al. Daily treatment with human recombinant parathyoid hormone(1-34), LY333334, for 1 year increases bone mass inovariectomiged monkeys. J Clin Endocrinol Metab, 1999,84: 3757-3763.
  • 9[9]Robert L, Carmelo F. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal woman on osetrogen with osteoporosis. LANCET, 1997,350:550-555.
  • 10[10]Finkelstein JS, Klibanski A, Arnold AL, et al. Prevention of estrogen deficiency-related bone loss with huamn parathyroid hormone(1-34) . JAMA, 1998,280:1067-1073.

共引文献26

同被引文献29

引证文献4

二级引证文献9

山东医药
2006年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部